Artificial Pancreas Device System Market - A Major Breakthrough in Diabetes Control: Infinium Global Research

PUNE, India, March 2, 2020 /PRNewswire/ -- The artificial pancreas device system is currently one of the focused medical devices in the medical field, as millions of people suffering from diabetes are going to benefit from it in future. Infinium global research has recently published a global report on "Artificial Pancreas Device System Market (Device Type - Control-to-Range (CTR) System, Threshold Suspended Device System, and Control-to-Target (CTT) System; Treatment Type - Bi-hormonal, Insulin Only, and Hybrid: Global Industry Analysis, Trends, Size, Share and Forecasts to 2025" published by Infinium Global Research", the reported study estimated the market for artificial pancreas device system will reach up to 377.62 million, with a compound annual growth rate of 20.5%, in the forecast period (2019-2025).

Closed-loop artificial pancreas device (APD) systems are externally worn medical devices that are being developed to enable people with type 1 diabetes to regulate their blood glucose levels in a more automated way. The innovative concept of this emerging technology is that hands-free, continuous, glycemic control can be achieved by using digital communication technology and advanced computer algorithm.

Rising Prevalence of Diabetes is anticipated to promote the demand for Artificial Pancreas Device Systems

The world is facing a huge rise in diabetic patients from the last few decades. This rising prevalence of diabetes globally has become one of the major factors that are driving the growth of the artificial pancreas device system market. Based on the stats provided by world health organization the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014 and the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. Moreover, the American Diabetes Association estimated that in 2018 there are more than 500 million prevalent cases of diabetes worldwide and the prevalence is comparable between high- and low-income countries. The prevalence will increase in all countries covered over the projection period, but the greatest growth will be experienced in lower-income countries.

Download Exclusive Sample Copy of Report: https://www.infiniumglobalresearch.com/reports/sample-request/12885          

Hassle free operations of the artificial pancreas device system over existing glucose monitoring devices is likely to boost the market.  

Another factor that is likely to boost the artificial pancreas device system market is the benefit of an artificial pancreas device system over continuous glucose monitors (CGMs) and insulin pumps to deliver continuous subcutaneous insulin infusion (CSII). As this system provides continuous monitoring of glucose level, the device operations are hands-free and more importantly it uses digital communication technology for glycaemic control.

On the other hand, low effectivity of the devices in the case of sportspersons can hamper the growth of the market, as a continuous glucose monitor measures glucose level in the tissue fluid, which does not change as quickly as the glucose level in the blood, which can lead to inappropriate dosing of insulin when the blood glucose is too high or too low. However, the rising dependency of insulin for type II diabetes is expected to provide virtuous opportunities for the growth of the market.

Control- to- Range (CTR) segment to show high growth during the forecast period

Global artificial pancreas device system market segmented based on device type, treatment type, and end-user. Device type segment categorized into Control-to- Range (CTR) System, Threshold Suspended Device System, and Control-to-Target (CTT) System. Based on the treatment type segment further bifurcated into bi-hormonal, insulin only and hybrid.

Asia Pacific region to register high growth during the forecast period.

North America especially, the U.S. dominates the global artificial pancreas device system market.  The presence of major digital healthcare such as Bigfoot Biomedical, Johnson & Johnson, Medtronic, TypeZero Technologies, Semma Therapeutics, Insulet Corp, and Beta Bionics among others are strengthening the root of the market in this region. On the other hand, rapidly increasing diabetic patient number in the Asia Pacific region provides excellent growth opportunities for the artificial pancreas device system market.

Need Assistance? Send an Enquiry@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-artificial-pancreas-device-system-market

Global Artificial Pancreas Device System Industry Coverage

Chapter - 1     Preface

• Report Description
• Research Methods
• Research Approaches

Chapter - 2     Executive Summary

• Artificial Pancreas Device System Market Highlights
• Artificial Pancreas Device System Market Projection
• Artificial Pancreas Device System Market Regional Highlights

Chapter - 3    Global Artificial Pancreas Device System Market Overview

• Introduction
• Market Dynamics
• Porter's Five Forces Analysis
• IGR-Growth Matrix Analysis
• Value Chain Analysis of Artificial Pancreas Device System Market

Chapter - 4     Artificial Pancreas Device System Market Macro Indicator Analysis

Chapter - 5     Global Artificial Pancreas Device System Market by Device Type

• Control-to-Range (CTR) System
• Threshold Suspended Device System
• Control-to-Target (CTT) System

Chapter - 6     Global Artificial Pancreas Device System Market by Treatment Type

• Bi-hormonal
• Insulin Only
• Hybrid

Chapter - 7     Global Artificial Pancreas Device System Market by Region 2019-2025

• North America
• Europe
• Asia-Pacific
• RoW

Chapter - 8     Company Profiles and Competitive Landscape

• Bigfoot Biomedical
• Johnson & Johnson
• Medtronic plc
• TypeZero Technologies
• Semma Therapeutics
• Insulet Corporation
• Beta Bionics
• Defymed
• Animas Corporation
• Tandem Diabetes Care
• Other companies

Browse in-depth TOC on "Artificial Pancreas Device System Market"

About Us

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

Contact:

Mr. Shrikant Athavale
Infinium Global Research
Office No. 103 and 104,
Suratwala Mark Plazzo,
Hinjawadi, Pune,
Maharashtra,
Pin- 411057.
USA: +1-888-500-3114
Email: [email protected] 
Research Insight: https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-artificial-pancreas-device-system-market
Visit Our Web Site: https://www.infiniumglobalresearch.com

SOURCE Infinium Global Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED